Author
St. Jude Children's Research HospitalORCID 0000-0002-1740-8139Unclaimed ORCID profile · follow to get notified of new preprints
6 papers
Recent·Most cited
Navneesh Yadav, Olivia Pelcher, Raja Gopal Reddy Mooli…·Kulandaimanuvel Antony Michealraj
This study identifies AHCY as a key driver of epigenetic and metabolic reprogramming in ZFTA-RELA ependymomas, revealing its role in promoting tumor growth through pyrimidine synthesis and asparagine dependency.
Bastian Krenz, Toshitha Kannan, Greta Mattavelli…·Martin Eilers
This study shows that MYC suppresses lysosomal protein degradation in pancreatic ductal adenocarcinoma, promoting immune evasion by altering amino acid availability and immune cell responses.
Jifeng Yang, Frédérique Zindy, Shaela Fields…·Chunliang Li
This study identifies CCL2 as a chemokine that limits osteosarcoma metastasis via NK cell signaling in a mouse model.
Jingjing Liu, Yang Xu, Mingrui Zhu…·Jiyang Yu
The paper introduces SINBA, a computational framework that identifies synergistic, brain-penetrant drug combinations for high-risk medulloblastoma, validating several candidates in preclinical models.
Rebecca R. J. Collins, Rebecca R. Florke Gee, Sima Tozandehjani…·Klementina Fon Tacer
This study identifies MAGE antigens as markers of tumor heterogeneity and species-specificity in group 3 medulloblastoma, showing their role in cell survival and potential as therapeutic targets.